LataMed AI Corp. (OTC: LMED), a healthcare technology company specializing in digital health and artificial intelligence for Latin America, has entered into an agreement with the Venezuelan Institute for Scientific Research (IVIC) to develop a digital platform module designed to facilitate access to laboratory and scientific services. This collaboration marks a strategic move for LataMed AI to extend its technological capabilities beyond patient-facing telemedicine into institutional and enterprise workflows.
The proposed module is intended to serve as a centralized digital interface through which authorized business and institutional users can request laboratory services, schedule appointments, monitor request status, access approved reports and documentation, and complete payment processes. The services to be made available will be determined by IVIC, ensuring alignment with technical, operational, security, and legal requirements. The platform aims to cater to sectors such as healthcare, pharmaceuticals, food production, agriculture, and related industries.
This initiative is significant because it demonstrates how LataMed AI's technology can be adapted for institutional use, potentially streamlining scientific service delivery in Venezuela and other Latin American countries. By digitizing these workflows, the platform could reduce inefficiencies, enhance transparency, and improve access to critical laboratory services, which are vital for research, quality control, and regulatory compliance in various industries.
Dr. Kevin Rodan Levy, CEO of LataMed AI, emphasized the importance of this partnership: "This agreement represents an opportunity to apply our technology to an important area of scientific and enterprise service delivery. Our objective is to work with IVIC to develop a responsible digital framework that makes it easier for authorized users to request services, manage appointments, monitor processes, and access approved information through a centralized platform."
The collaboration will involve defining functional requirements, user-access procedures, data architecture, payment workflows, document management, and a phased testing and implementation process. LataMed AI will also establish protocols for handling, transmitting, storing, and accessing laboratory-related information, ensuring data security and compliance.
If successfully implemented, this module could serve as a template for other institutional and enterprise service environments in the region. Management believes that the platform's potential to improve efficiency and accessibility in scientific services could lead to broader adoption, though any expansion would require separate agreements and regulatory approvals.
This development aligns with LataMed AI's broader strategy of building digital infrastructure that connects various stakeholders in the healthcare ecosystem, including patients, providers, pharmacies, insurers, and institutions. By venturing into laboratory services, the company is diversifying its offerings and demonstrating the versatility of its technology platform.
The agreement does not guarantee a specific implementation date or revenue generation, and the company has cautioned that the module's completion and success depend on technical development, testing, and user adoption. However, this partnership marks a significant step forward in LataMed AI's mission to enhance digital health and scientific services in Latin America.
For more information about LataMed AI and its initiatives, visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
